# Docetaxel

NDC: 0409-0366
Generic name: DOCETAXEL
Labeler / Manufacturer: Hospira, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20160824

FDA application: NDA022234

## Active ingredients

- DOCETAXEL: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0409-0366"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0409-0366
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3104aab1-cd6e-4ad2-8e0a-286a0c5d1940